Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept SC PK and Safety in RA
NCT00254293Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2006
- Primary completion
- May 2007
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Jan 2006; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00254293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254293.